Some recent studies have also provided evidence that PTL could act against many varieties of cancers, such as NSCLC (Talib and Al Kury, 2018) and breast cancer (Araujo et al., 2019; Berdan et al., 2019). This evidence concerns the gene PNLIP and non-small cell lung carcinoma.